Inventor · disambiguated record
Noriyuki Kasahara
Also filed as: KASAHARA NORIYUKI
21 granted patents·5 pending applications·259 citations·filing 1999–2022
95Inventor score
Files withUNIV CALIFORNIA6KASAHARA NORIYUKI5UNIV SOUTHERN CALIFORNIA4CICCIARELLI JAMES C3NAT INSTITUTE OF TRANSPLANTATION FOUNDATION3
Top patents by PatentIndex Score
26 records- 0194US9222105B2Methods and compositions for modification of the HPRT locusSANGAMO BIOSCIENCES INC·Filed 2012·Granted Dec 29, 2015·16 cites·29 claims
- 0293US6899871B2Gene delivery system and methods of useUNIV SOUTHERN CALIFORNIA·Filed 2002·Granted May 31, 2005·53 cites·21 claims
- 0392US8895264B2Methods and compositions for modification of the HPRT locusSANGAMO BIOSCIENCES INC·Filed 2012·Granted Nov 25, 2014·10 cites·17 claims
- 0490US9682106B2Method for combined conditioning and chemoselection in a single cycleUNIV CALIFORNIA·Filed 2016·Granted Jun 20, 2017·5 cites·44 claims
- 0589US8652460B2Gene delivery system and method of useKASAHARA NORIYUKI·Filed 2011·Granted Feb 18, 2014·6 cites·13 claims
- 0689US8236771B2Vectors and methods for long-term immune evasion to prolong transplant viabilityCICCIARELLI JAMES C·Filed 2005·Granted Aug 7, 2012·19 cites·4 claims
- 0788US10231998B2Method for chemoselectionUNIV CALIFORNIA·Filed 2017·Granted Mar 19, 2019·3 cites·41 claims
- 0887US8741279B2Gene delivery system and methods of useKASAHARA NORIYUKI·Filed 2002·Granted Jun 3, 2014·16 cites·62 claims
- 0987US6410313B1Gene delivery system and methods of useUNIV SOUTHERN CALIFORNIA·Filed 1999·Granted Jun 25, 2002·58 cites·39 claims
- 1086US6576463B1Hybrid vectors for gene therapyUNIV CALIFORNIA·Filed 2000·Granted Jun 10, 2003·26 cites·52 claims
- 1184US9439928B2Method for combined conditioning and chemoselection in a single cycleKASAHARA NORIYUKI·Filed 2012·Granted Sep 13, 2016·11 cites·18 claims
- 1283US10709739B2Method for chemoselectionUNIV CALIFORNIA·Filed 2019·Granted Jul 14, 2020·1 cites·28 claims
- 1381US7211247B2Lentivirus vectors for gene transfer to alveolar epithelial cellsUNIV SOUTHERN CALIFORNIA·Filed 2002·Granted May 1, 2007·15 cites·5 claims
- 1479US6806080B2Hybrid vectors for gene therapyUNIV SOUTHERN CALIFORNIA·Filed 2002·Granted Oct 19, 2004·13 cites·14 claims
- 1577US11065311B2Retroviral vector with mini-promoter cassetteDENOVO BIOPHARMA LLC·Filed 2013·Granted Jul 20, 2021·2 cites·40 claims
- 1677US10167486B2Vectors and methods for long-term immune evasion to prolong transplant viabilityNAT INSTITUTE OF TRANSPLANTATION FOUNDATION·Filed 2017·Granted Jan 1, 2019·2 cites·13 claims
- 1777US9677087B2Vectors and methods for long-term immune evasion to prolong tranplant viabilityCICCIARELLI JAMES C·Filed 2012·Granted Jun 13, 2017·3 cites·15 claims
- 1870US11607427B2Method for chemoselectionUNIV CALIFORNIA·Filed 2020·Granted Mar 21, 2023·0 cites·42 claims
- 1970US11060111B2Vectors and methods for long-term immune evasion to prolong transplant viabilityNAT INSTITUTE OF TRANSPLANTATION FOUNDATION·Filed 2018·Granted Jul 13, 2021·0 cites·5 claims
- 2064US2014234958A1Gene delivery system and method of useKASAHARA NORIYUKI·Filed 2014·Application pending·0 cites
- 2161US2024327866A1Regulated viral delivery systems and their usesUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2257US11143654B2Methods and kits for screening transplant recipients and candidatesNAT INSTITUTE OF TRANSPLANTATION FOUNDATION·Filed 2016·Granted Oct 12, 2021·0 cites·20 claims
- 2354US2024216514A1Novel antitumor compounds and related methods of manufacture and useKLOTHO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2451US2023304031A1Vectors and methods for in vivo transductionABINTUS BIO INC·Filed 2021·Application pending·0 cites
- 2547US9528988B2Methods and kits for screening transplant recipients and candidatesCICCIARELLI JAMES C·Filed 2010·Granted Dec 27, 2016·0 cites·51 claims
- 2645US2008008685A1Viral vectorsKASAHARA NORIYUKI·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Noriyuki Kasahara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →